WELICHEM BIOTECH
Welichem Biotech Inc. is a publicly-traded biotechnology company developing therapeutic drugs in the fields of autoimmune diseases and cancers.
WELICHEM BIOTECH
Social Links:
Industry:
Biotechnology Medical Device
Address:
Burnaby, British Columbia, Canada
Country:
Canada
Website Url:
http://www.welichem.com
Total Employee:
1+
Status:
Active
Contact:
16044321704
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Apps For Business Google Maps Google GStatic Google Static Content Google Maps API Google DNS
Similar Organizations
Ercole Biotech
Ercole Biotech, Inc., a research stage biopharmaceutical company, creates oligonucleotide drugs that achieve their therapeutic effect by
JA Bio
JA Bio is a biotech company that offers services for anti-tumor immune cell therapy drug development and medical device distribution.
Panther Biotechnology
Panther Biotechnology is a biotechnology company specializing in the acquisition and development of enhanced therapeutics.
Pulmo BioTech
Pulmo BioTech Inc is a development stage public company which intends to bring innovative and exciting molecular imaging.
Raze Therapeutics
Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics.
RemeGenix,
RemeGenix is a development stage biotechnology company, focused on the commercialization of disease-altering therapies.
UbiVac
UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer.
Current Employees Featured
Official Site Inspections
http://www.welichem.com
- Host name: 154.193.230.254
- IP address: 154.193.230.254
- Location: Johannesburg South Africa
- Latitude: -26.2309
- Longitude: 28.0583
- Timezone: Africa/Johannesburg
- Postal: 2000
More informations about "Welichem Biotech"
Welichem Biotech - Crunchbase Company Profile & Funding
Organization. Welichem Biotech . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Welichem Biotech is a development stage …See details»
Welichem Biotech, Inc. (Welichem Biotech, Inc.) - 药物管线_专利_ …
Welichem Biotech has developed a small molecule drug candidate, WBI-1001, that selectively targets the pathogenic features of inflammatory skin diseases, including atopic dermatitis (a …See details»
Welichem Biotech Inc., Burnaby, British Columbia
Through SymbioChem, its unique lead discovery system, Welichem is developing novel, small molecule compounds into new drugs of ... Toggle navigation Welichem Biotech Inc. Address: …See details»
Welichem Biotech, Inc. - Drug pipelines, Patents, Clinical trials
Explore Welichem Biotech, Inc. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 1 news, and 5 literature, Disease Domain:Neoplasms ...See details»
Welichem Biotech Company Profile 2024: Valuation, Investors
Welichem Biotech General Information Description. Developer of therapeutic drugs intended for autoimmune diseases. The company is engaged in the discovery and development of small …See details»
Welichem Biotech Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Welichem Biotech Inc of Burnaby, BC. Get the latest business insights from Dun & Bradstreet.See details»
Welichem Biotech - VentureRadar
Website archive shows the site HTTP://www.welichem.com was first archived on 2001. Similar Companies: LEO Pharma Denmark Listed We are an independent, research-based …See details»
Welichem Biotech - Contacts, Employees, Board Members
Organization. Welichem Biotech . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. Welichem …See details»
Welichem Biotech Inc. - Burnaby, Canada - bionity.com
Jan 13, 2009 Welichem announced that the Company has begun to enroll patients in a Phase IIb clinical trial with its lead candidate, WBI-1001. The Phase IIb clinical ... Read news . 13-Jan …See details»
Welichem Biotech - VentureRadar
Welichem BioTech Inc. is a Canadian Biotech Company focused on developing Autoimmune Inflammatory Disease and Cancer pharmaceutical drugs. ... Find out more about Welichem …See details»
Welichem Biotech Company Profile - Office Locations ... - Craft
Welichem Biotech has 1 employees at their 1 location. See insights on Welichem Biotech including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Welichem Biotech - Products, Competitors, Financials, Employees ...
Welichem's other lead drug candidate, WBI-2100, selectively targets certain types of hard-to-treat cancerous tumours. This is achieved in part through inhibition of angiogenesis and metastasis. …See details»
Welichem's Directors Affirm Recommendation that Shareholders
Jun 3, 2014 Welichem Biotech Inc. is a publicly-traded biotechnology company developing therapeutic drugs in the fields of autoimmune diseases and cancer. ... Organization Profile. …See details»
Liren Tang - President & CEO @ Welichem Biotech - Crunchbase
Prior to joining Welichem, Liren was a principal or co-principal investigator at the Vancouver Coastal Health Research Institute for diverse scientific and clinical research projects …See details»
Stiefel, a GSK company, enters into an agreement with Welichem …
May 30, 2012 Welichem Biotech Inc. is a publicly-traded biotechnology company developing therapeutic drugs in the fields of autoimmune diseases and cancers. ... Organization Profile. …See details»
Assets from Yukon's bankrupt Wolverine Mine up for quick sale
Jan 6, 2023 Bits and pieces of the Yukon's defunct Wolverine Mine are now up for grabs, as the company that owns the assets prepares for a quick sale. Welichem Equipment, a B.C. biotech …See details»
$230m GlaxoSmithKline deal welcome news for battered …
Aug 28, 2012 News that pharmaceutical giant GlaxoSmith Kline (GSK) has agreed to pay Vancouver-based Welichem Biotech Inc. up to $230 million for rights to a psoriasis cream is …See details»
Welichem and Stiefel, a GSK company, complete the acquisition by ...
Jul 31, 2012 Welichem Biotech Inc. is a publicly-traded biotechnology company developing therapeutic drugs in the fields of autoimmune diseases and cancers.See details»
Yukon government, creditor take disputes over Wolverine mine
Jun 8, 2021 Welichem, meanwhile, loaned Yukon Zinc more than $8.5 million in 2018, and also leased 572 pieces of equipment to the company for use at the Wolverine mine for $110,688 a …See details»
Kwalichem.com – Manufacturers of Organic Pigments and Violet …
As an organization, we are driven by the highest professional and ethical standards. By implementing the best industry practices, we ensure the health and safety of our workforce at …See details»